190 related articles for article (PubMed ID: 10354082)
21. Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases.
Robinson JC; Lozada-Nur F; Frieden I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):349-55. PubMed ID: 9347496
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effect of mizoribine on pemphigus vulgaris and pemphigus foliaceus.
Hashimoto T; Kawakami T; Koga H; Ohyama B; Hamada T; Dainichi T; Nakama T; Yasumoto S; Tsuruta D; Ishii N
Dermatol Ther; 2012; 25(4):382-5. PubMed ID: 22950566
[TBL] [Abstract][Full Text] [Related]
23. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
[TBL] [Abstract][Full Text] [Related]
24. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
[TBL] [Abstract][Full Text] [Related]
25. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
26. Successful management of Hailey-Hailey disease with potent topical steroid ointment.
Ikeda S; Suga Y; Ogawa H
J Dermatol Sci; 1993 Jun; 5(3):205-11. PubMed ID: 8241075
[TBL] [Abstract][Full Text] [Related]
27. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Jacobson C; Cornell RC; Savin RC
Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
[TBL] [Abstract][Full Text] [Related]
28. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
[TBL] [Abstract][Full Text] [Related]
29. Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis.
Motta AC; Domaneschi C; Komesu MC; Souza Cda S; Aoki V; Migliari DA
Braz Dent J; 2009; 20(3):231-6. PubMed ID: 19784470
[TBL] [Abstract][Full Text] [Related]
30. Clobetasol propionate foam, 0.05%.
Melian EB; Spencer CM; Jarvis B
Am J Clin Dermatol; 2001; 2(2):89-92; discussion 93. PubMed ID: 11705308
[TBL] [Abstract][Full Text] [Related]
31. Four mild but refractory cases of pemphigus foliaceus successfully treated with intravenous immunoglobulin.
Kawakami T; Koga H; Saruta H; Ueda A; Inoue Y; Soma Y; Ishii N; Hashimoto T
J Dermatol; 2013 Nov; 40(11):869-73. PubMed ID: 24127870
[TBL] [Abstract][Full Text] [Related]
32. Eumovate (clobetasone butyrate) 0.05% cream with its moisturizing emollient base has better healing properties than hydrocortisone 1% cream: a study in nickel-induced contact dermatitis.
Parneix-Spake A; Goustas P; Green R
J Dermatolog Treat; 2001 Dec; 12(4):191-7. PubMed ID: 12241627
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and histopathologic picture of lichen sclerosus treated with clobetasol propionate].
Rotsztejn H; Krawczyk T; Nadel I; Połać I; Tchórzewski H; Pertyński T
Pol Merkur Lekarski; 1999 Nov; 7(41):224-5. PubMed ID: 10680456
[TBL] [Abstract][Full Text] [Related]
34. A Case of pemphigus foliaceus which occurred after five years of remission from pemphigus vulgaris.
Kimoto M; Ohyama M; Hata Y; Amagai M; Nishikawa T
Dermatology; 2001; 203(2):174-6. PubMed ID: 11586021
[TBL] [Abstract][Full Text] [Related]
35. Childhood pemphigus foliaceus: case report and review of the literature.
Jones SK; Schwab HP; Norris DA
Pediatr Dermatol; 1986 Dec; 3(6):459-63. PubMed ID: 3562360
[TBL] [Abstract][Full Text] [Related]
36. Lichen sclerosus. Therapy with clobetasol propionate.
Lorenz B; Kaufman RH; Kutzner SK
J Reprod Med; 1998 Sep; 43(9):790-4. PubMed ID: 9777618
[TBL] [Abstract][Full Text] [Related]
37. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays.
Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Morales-Garcia P; Mesa-Aguado F; Bascones-Martinez A; Bravo M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):688-92. PubMed ID: 12789149
[TBL] [Abstract][Full Text] [Related]
38. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
Coskun B; Saral Y; Turgut D
Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
[TBL] [Abstract][Full Text] [Related]
40. Pemphigus vulgaris treated with adalimumab: case study.
Vojáčková N; Fialová J; Vaňousová D; Hercogová J
Dermatol Ther; 2012; 25(1):95-7. PubMed ID: 22591504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
